Clinical Trials in Phoenix

Showing 5281-5300 of 16,646 trials

Atezolizumab With Bevacizumab in Previously Untreated Metastatic/Unresectable Urothelial Cancer

NCT03272217

This is a phase II study assessing the activity of bevacizumab combined with atezolizumab in metastatic urothelial carcinoma patients who are ineligible for cisplatin-based therapy.

Urothelial Carcinoma

Arjun Balar, MD16 participantsStarted Sep 2017

Phoenix, Arizona, United States • Chicago, Illinois, United States • Minneapolis, Minnesota, United States +5 more locations

COMPLETEDPhase 311 miles

Open-Label Extension Trial of PDE4 Inhibition With Roflumilast for the Management of Plaque Psoriasis

NCT04286607

This study will assess the safety and efficacy of ARQ-151 cream applied once a day for 24 weeks by subjects with chronic plaque psoriasis

Chronic Plaque Psoriasis

Arcutis Biotherapeutics, Inc.333 participantsStarted Feb 2020

Scottsdale, Arizona, United States • Beverly Hills, California, United States • Encinitas, California, United States +82 more locations

Atezolizumab With Bevacizumab in Previously Untreated Metastatic/Unresectable Urothelial Cancer

Open-Label Extension Trial of PDE4 Inhibition With Roflumilast for the Management of Plaque Psoriasis

Find Trials by Condition in Phoenix

A Study of NST-6179 in Subjects With Intestinal Failure-Associated Liver Disease (IFALD).

EMPACT-MI: A Study to Test Whether Empagliflozin Can Lower the Risk of Heart Failure and Death in People Who Had a Heart Attack (Myocardial Infarction)

CtDNA Based MRD Testing for NAC Monitoring in TNBC

AZD9291 (Osimertinib) Versus Platinum-Based Doublet-Chemotherapy in Locally Advanced or Metastatic Non-Small Cell Lung Cancer

The Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care Versus Placebo and Best Supportive Care in Subjects With Red Blood Cell (RBC) Transfusion-Dependent Anemia and Thrombocytopenia Due to International Prognostic Scoring System (IPSS) Low Risk Myelodysplastic Syndrome (MDS)

Evaluation of Buprenorphine Extended-Release Subcutaneous Injection at Alternative Injection Locations

PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - S3 Intermediate

A Pharmacokinetic Study of Simufilam in Subjects With Impaired Hepatic Function

A Study to Investigate Efficacy and Safety of KBL697 in Patients with Moderate Plaque Type Psoriasis

A Study of LY3509754 in Healthy Non-Japanese and Japanese Participants

A Phase I/II Study of AZD0466 as Monotherapy or in Combination With Anticancer Agents in Advanced Non-Hodgkin Lymphoma

Study of AMG 994 Monotherapy and AMG 994 and AMG 404 Combination Therapy in Participants With Advanced Solid Tumors

A Study of NOX66 Plus Doxorubicin in Anthracycline-naïve, Adult Patients With Soft Tissue Sarcoma

Study to Assess the Long-term Safety of Lenvatinib Monotherapy, a Lenvatinib Combination Regimen, or a Comparator Treatment Arm to Cancer Participants in Eisai Sponsored Lenvatinib Trials

Talimogene Laherparepvec With Pembrolizumab in Melanoma Following Progression on Prior Anti-PD-1 Based Therapy (MASTERKEY-115) (Mk-3475-A07/KEYNOTE-A07).

Study to Measure Cerebrospinal Fluid Mutant Huntingtin Protein in Participants With Early Manifest Stage I or Stage II Huntington's Disease

A Study Evaluating the Safety and Efficacy of HB0036 in Subjects With Advanced Solid Tumors

Predictive Factors for Medullary Thyroid Cancer Aggressiveness